血塞通联合奥扎格雷钠治疗急性脑梗死疗效观察 |
| |
引用本文: | 游建明. 血塞通联合奥扎格雷钠治疗急性脑梗死疗效观察[J]. 实用中医内科杂志, 2010, 24(5): 52-53. DOI: 10.3969/j.issn.1671-7813.2010.05.31 |
| |
作者姓名: | 游建明 |
| |
作者单位: | 湖南省浏阳市中医院,湖南浏阳,410030 |
| |
摘 要: | [目的]观察血塞通联合奥扎格雷钠治疗急性脑梗死的临床疗效。[方法]将85例分为治疗组和对照组,对照组给予奥扎格雷钠80mg/日,治疗组在此基础上加用血塞通0.8g/日,连续14日。观察两组治疗前后临床神经功能缺损程度较治疗前有所改善(P<0.05),但治疗组改善更明显(P<0.05)。治疗14日后临床疗效评价,治疗组总有效率(87.5%)较对照组(67.5%)差异有显著性(P<0.05)。两组治疗后纤维蛋白原含量均比治疗前有显著下降(P<0.05)。治疗组与对照组比较有显著差异性(P<0.05)。[结论]血塞通联合奥扎格雷钠治疗急性脑梗死效果明显。
|
关 键 词: | 急性脑梗死 血塞通 奥扎格雷钠 纤维蛋白原 |
Ozagrel Sodium Sodium Xuesaitong Combined Treatment of Acute Cerebral Infarction |
| |
Affiliation: | YOU Jian - ming (Liuyang Chinese Medicine Hospital,Liuyang 410030,Hunan,China) |
| |
Abstract: | [ Objective ] To observe the combined Ozagrel sodium Xuesaitong the clinical efficacy of the treatment of acute cerebral infarction. [ Methods ] 85 patients were divided into treatment group and control group, control group was given Ozagrel sodium 80rag/day, on this basis, the treatment group was added Xuesaitong 0.8g/day, continuous 14 days. Were observed before and after treatment of clinical neurologic impairment score, fibrinogen content changes. [ Results ] After treatment, the clinical neurological deficits before treatment improved ( P 〈 0.05 ), but the treatment group improved more significantly ( P 〈 0.05). Clinical Evaluation of the treatment 14 days after the treatment group, the total effective rate (87.5%) than in the control group (67.5%), the difference was significant (P 〈0.05). The two groups after treatment than that before treatment fibrinogen concentration decreased significantly ( P 〈 0.05 ). The treatment group compared with the control group significant difference ( P 〈 0. 05 ). [ Conclusion ] Ozagrel sodium Xuesaitong combined effect of the treatment of acute cerebral infarction significantly, treatment of cerebral infarction effect is remarkable. |
| |
Keywords: | acute cerebral infarction Xuesaitong ozagrel sodium sodium |
本文献已被 维普 万方数据 等数据库收录! |
|